Catherine A Tucker

Summary

Country: Canada

Publications

  1. ncbi Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma
    Catherine A Tucker
    The Department of Advanced Therapeutics, BC Cancer Research Center, 675 West 10th Avenue, 5th Floor, Vancouver, BC, Canada
    Leuk Res 30:449-57. 2006
  2. ncbi Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels
    Catherine A Tucker
    Department of Advanced Therapeutics, BC Cancer Research Center, Vancouver, British Columbia, Canada V5Z 1L3
    Mol Cancer Ther 7:749-58. 2008

Detail Information

Publications2

  1. ncbi Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma
    Catherine A Tucker
    The Department of Advanced Therapeutics, BC Cancer Research Center, 675 West 10th Avenue, 5th Floor, Vancouver, BC, Canada
    Leuk Res 30:449-57. 2006
    ..The results of the characterization of Z-138, HBL-2, NCEB-1 and JVM-2 reveal that this group of cell lines represents both classic and variant features of MCL...
  2. ncbi Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels
    Catherine A Tucker
    Department of Advanced Therapeutics, BC Cancer Research Center, Vancouver, British Columbia, Canada V5Z 1L3
    Mol Cancer Ther 7:749-58. 2008
    ..Coimmunoprecipitation studies indicate that bcl-2 may mediate its effects on cyclin D1a via interaction with p38 mitogen-activated protein kinase as well as a previously unreported interaction between bcl-2 and cyclin D1a...